期刊
HUMAN GENE THERAPY
卷 26, 期 5, 页码 276-285出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/hum.2015.024
关键词
-
资金
- Experimental Cancer Medicine Centre at King's College London
- National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust
- King's College London
- Leukaemia & Lymphoma Research Bennett Senior Fellowship [12004]
- NIHR GOSH biomedical research center
- GOSHCC charity
- Medical Research Council/Technology Strategy Board project grant [TS/J003530/1]
- Leukaemia and Lymphoma Research and Children with Cancer
- LLR
- MRC
- ECMC
- BRC
- CRUK
- Cancer Research UK
- Tenovus Cancer Care
- Cancer Research Wales
- Cancer Research UK [15152, 14779] Funding Source: researchfish
- Great Ormond Street Hospital Childrens Charity [W1060, V1243] Funding Source: researchfish
- Medical Research Council [MR/K500732/1, G0902209] Funding Source: researchfish
- National Institute for Health Research [RP-2014-05-007] Funding Source: researchfish
- MRC [G0902209] Funding Source: UKRI
Adoptive T-cell therapy is delivering objective clinical responses across a number of cancer indications in the early phase clinical setting. Much of this clinical activity is taking place at major clinical academic centers across the United States. This review focuses upon cancer-focused cell therapy activity within the United Kingdom as a contribution to the 2015 British Society of Gene and Cell Therapy annual general meeting. This overview reflects the diversity and expansion of clinical and preclinical studies within the United Kingdom while considering the background context of this work against new infrastructural developments and the requirements of nationalized healthcare delivery within the UK National Health Service.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据